Literature DB >> 11408287

Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe-but there's no good evidence that it works.

J Chard, P Dieppe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408287      PMCID: PMC1120508          DOI: 10.1136/bmj.322.7300.1439

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  15 in total

Review 1.  Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint.

Authors:  J A Chard; D Tallon; P A Dieppe
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

3.  Language bias in randomised controlled trials published in English and German.

Authors:  M Egger; T Zellweger-Zähner; M Schneider; C Junker; C Lengeler; G Antes
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

4.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

Review 5.  The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease.

Authors:  G S Kelly
Journal:  Altern Med Rev       Date:  1998-02

6.  [Topical therapy of arthroses with glucosamines (Dona 200)].

Authors:  G Vetter
Journal:  Munch Med Wochenschr       Date:  1969-07-11

7.  A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.

Authors:  P A Rochon; J H Gurwitz; R W Simms; P R Fortin; D T Felson; K L Minaker; T C Chalmers
Journal:  Arch Intern Med       Date:  1994-01-24

8.  Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.

Authors:  C Bassleer; L Rovati; P Franchimont
Journal:  Osteoarthritis Cartilage       Date:  1998-11       Impact factor: 6.576

9.  Factors associated with functional impairment in symptomatic knee osteoarthritis.

Authors:  P Creamer; M Lethbridge-Cejku; M C Hochberg
Journal:  Rheumatology (Oxford)       Date:  2000-05       Impact factor: 7.580

10.  Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study.

Authors:  A Reichelt; K K Förster; M Fischer; L C Rovati; I Setnikar
Journal:  Arzneimittelforschung       Date:  1994-01
View more
  12 in total

1.  Glucosamine for osteoarthritis. Patients' welfare should be primary concern.

Authors:  D Sonnino
Journal:  BMJ       Date:  2001-10-27

Review 2.  Nutritional genomics.

Authors:  Ruan Elliott; Teng Jin Ong
Journal:  BMJ       Date:  2002-06-15

3.  Non-surgical treatment of osteoarthritis: a half century of "advances".

Authors:  K D Brandt
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

4.  Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women.

Authors:  D Sibbritt; C Lui; T Kroll; J Adams
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

5.  Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal.

Authors:  Philip J Gregory; Chris Fellner
Journal:  P T       Date:  2014-06

Review 6.  Glucosamine: a review of its use in the management of osteoarthritis.

Authors:  Anna J Matheson; Caroline M Perry
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  'Natural remedies' in the treatment of osteoarthritis.

Authors:  Karen Walker-Bone
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta.

Authors:  Jean-Noël Gouze; Elvire Gouze; Mick P Popp; Marsha L Bush; Emil A Dacanay; Jesse D Kay; Padraic P Levings; Kunal R Patel; Jeet-Paul S Saran; Rachael S Watson; Steven C Ghivizzani
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older.

Authors:  David Sibbritt; Jon Adams; Chi-Wai Lui; Alex Broom; Jonathan Wardle
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

10.  Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report.

Authors:  Wim J van Blitterswijk; Jos C M van de Nes; Paul I J M Wuisman
Journal:  BMC Complement Altern Med       Date:  2003-06-10       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.